Broughton shares PMTA learnings at GTNF
September 26, 2022
A new paper, Strategic insights to reignite PMTA confidence: Reduce costs and protect timelines whilst continuing to innovate, has been ...
Youth vaping in the UK
September 21, 2022
Will an increase in youth vaping derail the UK’s commitment to a smoke-free future? The last couple of months has seen the release of two ...
Reflections on the 75th Tobacco Science Research ...
September 20, 2022
Broughton Senior Consultant for Chemistry, Malcolm Saxton reflects on the 75th Tobacco Science Research Conference (TSRC) and the progress ...
Modern Oral Nicotine Products need clear ...
July 7, 2022
Modern Oral Nicotine Products (MONPs) are another exciting product innovation that can support the cause of worldwide tobacco harm ...
Positive steps but still many challenges - the ...
July 4, 2022
Broughton's Chief Executive Officer, Chris Allen summarizes the highlights from Global Forum on Nicotine (GFN).
Broughton shares the highlights from Next ...
June 24, 2022
Broughton's Chief Commercial Officer, Andy Mooney summarizes the highlights from Next Generation Nicotine Delivery Conference USA.
The end of e-cigarette regulation uncertainty in ...
January 12, 2022
Broughton's Head of Regulatory Affairs, Lloyd Smart, and Regulatory Consultant, Xiangyin Wei summarise China's Tobacco Monopoly Law Changes ...
What manufacturers should know about the medical ...
December 3, 2021
Broughton's Head of Regulatory Affairs, Lloyd Smart has recently published an article with the leading sector publication Tobacco Reporter.
The race to register e-cigarettes as medicinal ...
November 30, 2021
Broughton's Chief Scientific Officer, Chris Allen shares his opinion with Financial Times about e-cigarettes on the NHS.
